Skip to results
Modify your search
NARROW
1-20 of 21
Authors: Jonas Oldgren
Sort by
Journal Article
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry Open Access
Linda S Johnson and others
European Heart Journal, Volume 45, Issue 26, 7 July 2024, Pages 2336–2340, https://doi.org/10.1093/eurheartj/ehae319
Published: 04 June 2024
Journal Article
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation Open Access
Ziad Hijazi and others
European Heart Journal, Volume 44, Issue 3, 14 January 2023, Pages 208–218, https://doi.org/10.1093/eurheartj/ehac632
Published: 16 November 2022
Journal Article
EDITOR'S CHOICE
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation Free
Lars Wallentin and others
European Heart Journal, Volume 41, Issue 41, 1 November 2020, Pages 4037–4046, https://doi.org/10.1093/eurheartj/ehaa697
Published: 27 September 2020
Journal Article
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial Open Access
Jonas Oldgren and others
European Heart Journal, Volume 40, Issue 19, 14 May 2019, Pages 1553–1562, https://doi.org/10.1093/eurheartj/ehz059
Published: 21 February 2019
Journal Article
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials Open Access
Harsh B Golwala and others
European Heart Journal, Volume 39, Issue 19, 14 May 2018, Pages 1726–1735a, https://doi.org/10.1093/eurheartj/ehy162
Published: 13 April 2018
Journal Article
EDITOR'S CHOICE
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial Open Access
Michael D Ezekowitz and others
European Heart Journal, Volume 39, Issue 32, 21 August 2018, Pages 2959–2971, https://doi.org/10.1093/eurheartj/ehy148
Published: 06 April 2018
Journal Article
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Get access
Jan Steffel and others
European Heart Journal, Volume 39, Issue 16, 21 April 2018, Pages 1330–1393, https://doi.org/10.1093/eurheartj/ehy136
Published: 19 March 2018
Journal Article
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score Open Access
Ziad Hijazi and others
European Heart Journal, Volume 39, Issue 6, 07 February 2018, Pages 477–485, https://doi.org/10.1093/eurheartj/ehx584
Published: 21 October 2017
Journal Article
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS Free
Paulus Kirchhof and others
European Heart Journal, Volume 37, Issue 38, 7 October 2016, Pages 2893–2962, https://doi.org/10.1093/eurheartj/ehw210
Published: 27 August 2016
Journal Article
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary Free
Hein Heidbuchel and others
European Heart Journal, Volume 38, Issue 27, 14 July 2017, Pages 2137–2149, https://doi.org/10.1093/eurheartj/ehw058
Published: 09 June 2016
Journal Article
EDITOR'S CHOICE
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation Open Access
Ziad Hijazi and others
European Heart Journal, Volume 37, Issue 20, 21 May 2016, Pages 1582–1590, https://doi.org/10.1093/eurheartj/ehw054
Published: 25 February 2016
Journal Article
EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary
Get access
Hein Heidbuchel and others
European Heart Journal, Volume 34, Issue 27, 14 July 2013, Pages 2094–2106, https://doi.org/10.1093/eurheartj/eht134
Published: 26 April 2013
Journal Article
New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis Open Access
Jonas Oldgren and others
European Heart Journal, Volume 34, Issue 22, 7 June 2013, Pages 1670–1680, https://doi.org/10.1093/eurheartj/eht049
Published: 06 March 2013
Journal Article
NOVEL THERAPEUTIC CONCEPTS
Biomarkers in atrial fibrillation: a clinical review
Get access
Ziad Hijazi and others
European Heart Journal, Volume 34, Issue 20, 21 May 2013, Pages 1475–1480, https://doi.org/10.1093/eurheartj/eht024
Published: 05 February 2013
Journal Article
Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden
Get access
Thomas Davidson and others
European Heart Journal, Volume 34, Issue 3, 14 January 2013, Pages 177–183, https://doi.org/10.1093/eurheartj/ehs157
Published: 24 June 2012
Journal Article
EDITOR'S CHOICE
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial
Get access
Jonas Oldgren and others
European Heart Journal, Volume 32, Issue 22, November 2011, Pages 2781–2789, https://doi.org/10.1093/eurheartj/ehr113
Published: 07 May 2011
Journal Article
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial
Get access
Ron J.G. Peters and others
European Heart Journal, Volume 29, Issue 3, February 2008, Pages 324–331, https://doi.org/10.1093/eurheartj/ehm616
Published: 01 February 2008
Journal Article
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment Open Access
Jonas Oldgren and others
European Heart Journal, Volume 29, Issue 3, February 2008, Pages 315–323, https://doi.org/10.1093/eurheartj/ehm578
Published: 15 December 2007
Journal Article
Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM: reply
Get access
Christina Christersson and others
European Heart Journal, Volume 28, Issue 14, July 2007, Page 1783, https://doi.org/10.1093/eurheartj/ehm140
Published: 03 May 2007
Journal Article
Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients
Get access
Jonas Oldgren and others
European Heart Journal, Volume 28, Issue 6, March 2007, Pages 699–704, https://doi.org/10.1093/eurheartj/ehl565
Published: 21 February 2007
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals